State of the Practice: Rectal Cancer

Monday, May 2, 8:15 - 9:15 am

CME Credit Hours: 1

There are now several viable options in managing most rectal cancers. These include numerous options for resection, neoadjuvant treatment, surveillance, and management of metastatic disease. This symposium will provide an overview of the management of common presentations of rectal cancer and novel approaches to treatment.


At the conclusion of this session, participants should be able to:
  1. Explain when and how to treat rectal cancer patients with Total Neoadjuvant Therapy
  2. Describe the management options of a resected malignant polyp
  3. Explain the management of Stage IV disease including when to perform salvage surgery


Melanie Morris, MD, Birmingham, AL

Mark Whiteford, MD, Portland, OR
8:15 am               
Melanie Morris, MD, Birmingham, AL
Mark Whiteford, MD, Portland, OR
8:20 am               
Resected Malignant Rectal Polyp: Now What? 
Imran Hassan, MD, Cedar Rapids, IA
8:27 am               
TNT: How to Do it and When to Perform Surveillance
Daniel Herzig, MD, Portland, OR
8:34 am               
Management of Stage IV Disease: Symptomatic vs Asymptomatic
James Fleshman, Jr., MD, Dallas, TX
8:41 am               
Salvage Surgery: Local Recurrence, Distant Mets, and Multivisceral Resections
Karin Hardiman, MD, PhD, Birmingham, AL
8:48 am               
9:15 am